These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31861546)

  • 21. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene trap mutagenesis of hnRNP A2/B1: a cryptic 3' splice site in the neomycin resistance gene allows continued expression of the disrupted cellular gene.
    Roshon M; DeGregori JV; Ruley HE
    BMC Genomics; 2003 Jan; 4(1):2. PubMed ID: 12546712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered expression of splicing factor, heterogeneous nuclear ribonucleoprotein A2/B1, in mouse lung neoplasia.
    Peebles KA; Dwyer-Nield LD; Malkinson AM
    Mol Carcinog; 2007 Nov; 46(11):887-900. PubMed ID: 17477362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypically different cells with heterogeneous nuclear ribonucleoprotein A2/B1 overexpression show similar genetic alterations.
    Man YG; Martinez A; Avis IM; Hong SH; Cuttitta F; Venzon DJ; Mulshine JL
    Am J Respir Cell Mol Biol; 2000 Nov; 23(5):636-45. PubMed ID: 11062142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer.
    Zhou J; Allred DC; Avis I; Martínez A; Vos MD; Smith L; Treston AM; Mulshine JL
    Breast Cancer Res Treat; 2001 Apr; 66(3):217-24. PubMed ID: 11510693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel role of hnRNP-A2/B1 in modulating aryl hydrocarbon receptor ligand sensitivity.
    Cho SW; Suzuki K; Miura Y; Miyazaki T; Nose M; Iwata H; Kim EY
    Arch Toxicol; 2015 Nov; 89(11):2027-38. PubMed ID: 25224401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression.
    Tockman MS; Mulshine JL; Piantadosi S; Erozan YS; Gupta PK; Ruckdeschel JC; Taylor PR; Zhukov T; Zhou WH; Qiao YL; Yao SX
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2237-46. PubMed ID: 9815620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous nuclear ribonucleoprotein A2/B1 in association with hTERT is a potential biomarker for hepatocellular carcinoma.
    Mizuno H; Honda M; Shirasaki T; Yamashita T; Yamashita T; Mizukoshi E; Kaneko S
    Liver Int; 2012 Aug; 32(7):1146-55. PubMed ID: 22372738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of hnRNP A2/B1 Knockdown on Inhibition of Glioblastoma Cell Invasion, Growth and Survival.
    Deng J; Chen S; Wang F; Zhao H; Xie Z; Xu Z; Zhang Q; Liang P; Zhai X; Cheng Y
    Mol Neurobiol; 2016 Mar; 53(2):1132-1144. PubMed ID: 25586062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of hnRNP A2/B1 in human lung cancer cell lines].
    Wu C; Li W; Chen W; Xu D; Wei D; Zhou Q
    Zhongguo Fei Ai Za Zhi; 2004 Apr; 7(2):121-4. PubMed ID: 21215005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers.
    Zhou J; Mulshine JL; Ro JY; Avis I; Yu R; Lee JJ; Morice R; Lippman SM; Lee JS
    Clin Cancer Res; 1998 Jul; 4(7):1631-40. PubMed ID: 9676837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers.
    Sueoka E; Goto Y; Sueoka N; Kai Y; Kozu T; Fujiki H
    Cancer Res; 1999 Apr; 59(7):1404-7. PubMed ID: 10197602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testis- and developmental stage-specific expression of hnRNP A2/B1 splicing isoforms, B0a/b.
    Matsui M; Horiguchi H; Kamma H; Fujiwara M; Ohtsubo R; Ogata T
    Biochim Biophys Acta; 2000 Sep; 1493(1-2):33-40. PubMed ID: 10978504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization of the hnRNP A2/B1 proteins: tissue-specific expression and novel isoforms.
    Kamma H; Horiguchi H; Wan L; Matsui M; Fujiwara M; Fujimoto M; Yazawa T; Dreyfuss G
    Exp Cell Res; 1999 Feb; 246(2):399-411. PubMed ID: 9925756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: a clinical marker of early lung cancer detection.
    Fielding P; Turnbull L; Prime W; Walshaw M; Field JK
    Clin Cancer Res; 1999 Dec; 5(12):4048-52. PubMed ID: 10632338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cloning, ligation and expression of the variable region genes of the monoclonal antibody against human HnRNPA2/B1].
    Wang X; Peng XD; Li G; Hu LJ; Bi JH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):548-51. PubMed ID: 15583979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
    Gu WJ; Liu HL
    Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Splicing factor hnRNP A2/B1 regulates tumor suppressor gene splicing and is an oncogenic driver in glioblastoma.
    Golan-Gerstl R; Cohen M; Shilo A; Suh SS; Bakàcs A; Coppola L; Karni R
    Cancer Res; 2011 Jul; 71(13):4464-72. PubMed ID: 21586613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein-RNA Networks Regulated by Normal and ALS-Associated Mutant HNRNPA2B1 in the Nervous System.
    Martinez FJ; Pratt GA; Van Nostrand EL; Batra R; Huelga SC; Kapeli K; Freese P; Chun SJ; Ling K; Gelboin-Burkhart C; Fijany L; Wang HC; Nussbacher JK; Broski SM; Kim HJ; Lardelli R; Sundararaman B; Donohue JP; Javaherian A; Lykke-Andersen J; Finkbeiner S; Bennett CF; Ares M; Burge CB; Taylor JP; Rigo F; Yeo GW
    Neuron; 2016 Nov; 92(4):780-795. PubMed ID: 27773581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of hnRNP A2 and B1 using monoclonal antibodies: intracellular distribution and metabolism through cell cycle.
    Kamma H; Satoh H; Matusi M; Wu WW; Fujiwara M; Horiguchi H
    Immunol Lett; 2001 Feb; 76(1):49-54. PubMed ID: 11222913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.